Literature DB >> 2707840

Efficacy of tinidazole (Fasigyn) in giardiasis by parasitologic, biochemical, and gut transit studies.

J P Gupta, A K Jain, A S Nanivadekar.   

Abstract

Twenty patients (18 M, 2 F; age 16-32 yrs) with symptomatic giardiasis were treated with tinidazole: ten each with a dose of 150 mg twice daily for 7 days, and a single dose of 2 g (50 mg/kg). Stool examination by formalin-ether concentration method was carried out before and one month after treatment. Cure was defined as absence of G lamblia in the stools. Fecal fat excretion (100 g load) and D-xylose absorption (5 g load) were measured before treatment and, if abnormal, repeated one month after treatment. Gut transit time was measured before and one month after treatment by giving radio-opaque beads orally and following their progress fluoroscopically to complete elimination. Parasitologically, all 20 patients were cured. Clinically, there was marked to complete relief of symptoms. Concomitantly, there was significant (p less than 0.01) reduction in fecal fat excretion, improvement in D-xylose absorption, and increase in gut transit time.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2707840

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN: 0254-8860


  4 in total

Review 1.  WITHDRAWN: Drugs for treating giardiasis.

Authors:  J O M Zaat; T H G Mank; W J J Assendelft
Journal:  Cochrane Database Syst Rev       Date:  2007-07-18

2.  Effects of Giardia lamblia infection on gastrointestinal transit and contractility in Mongolian gerbils.

Authors:  L P Deselliers; D T Tan; R B Scott; M E Olson
Journal:  Dig Dis Sci       Date:  1997-12       Impact factor: 3.199

3.  Single-dose ornidazole versus seven-day metronidazole therapy of giardiasis in Kibbutzim children in Israel.

Authors:  B Oren; E Schgurensky; M Ephros; I Tamir; R Raz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-11       Impact factor: 3.267

Review 4.  Clinical research: A personal perspective.

Authors:  Arun S Nanivadekar
Journal:  Perspect Clin Res       Date:  2017 Jan-Mar
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.